stocktools
Offerings // REGENTIS BIOMATERIALS LTD.

RGNT offering history

Every offering-related filing in REGENTIS BIOMATERIALS LTD.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 70 filings back to Mar 29, 2022.

Last executed offering
None found
in filings back to Mar 29, 2022
Last registration (announced)
Jul 8, 2026
F-1 — capacity, not a sale
Executed, last 12 months
0
424B pricings + 8-K 3.02 sales
Registered, last 12 months
6
S-1/S-3/F-series registrations
DateFilingWhat it means
Jul 13, 2026424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Jul 13, 2026EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Jul 8, 2026F-1 →REGISTEREDF-1 registration — capacity to sell shares, not a sale yet
Jun 15, 2026RW →WITHDRAWNRegistration withdrawn
Jun 9, 2026F-1/A →REGISTEREDF-1/A registration — capacity to sell shares, not a sale yet
May 29, 2026FWP →MARKETINGFree-writing prospectus — offering being marketed
May 1, 2026F-1 →REGISTEREDF-1 registration — capacity to sell shares, not a sale yet
Dec 4, 2025424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Oct 24, 2025F-1/A →REGISTEREDF-1/A registration — capacity to sell shares, not a sale yet
Oct 24, 2025FWP →MARKETINGFree-writing prospectus — offering being marketed
Oct 6, 2025FWP →MARKETINGFree-writing prospectus — offering being marketed
Sep 30, 2025F-1/A →REGISTEREDF-1/A registration — capacity to sell shares, not a sale yet
Sep 9, 2025F-1/A →REGISTEREDF-1/A registration — capacity to sell shares, not a sale yet
Jul 7, 2025F-1/A →REGISTEREDF-1/A registration — capacity to sell shares, not a sale yet
Jul 7, 2025FWP →MARKETINGFree-writing prospectus — offering being marketed
May 19, 2025F-1/A →REGISTEREDF-1/A registration — capacity to sell shares, not a sale yet
May 5, 2025F-1/A →REGISTEREDF-1/A registration — capacity to sell shares, not a sale yet
Mar 11, 2025F-1 →REGISTEREDF-1 registration — capacity to sell shares, not a sale yet
Nov 21, 2024RW →WITHDRAWNRegistration withdrawn
Dec 19, 2022F-1/A →REGISTEREDF-1/A registration — capacity to sell shares, not a sale yet
Dec 7, 2022F-1/A →REGISTEREDF-1/A registration — capacity to sell shares, not a sale yet
Nov 4, 2022F-1 →REGISTEREDF-1 registration — capacity to sell shares, not a sale yet
RGNT offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full RGNT workspace →
RGNT offering FAQ

When did RGNT last execute an offering?

No executed-offering document (424B pricing supplement or 8-K item 3.02) appears in the 70 filings EDGAR returns for REGENTIS BIOMATERIALS LTD., reviewed back to 2022-03-29.

When did RGNT last announce or register an offering?

The most recent registration is a F-1 filed 2026-07-08. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.